Versant Ventures Nabs $400M For Biotech Investment Fund
Versant Ventures, a private investment firm focused on the health care industry, on Tuesday said that it has closed its latest fund after raising $400 million from investors, with plans to...To view the full article, register now.
Already a subscriber? Click here to view full article